Nav: Home

Alexander N. Zelikin receives the 2016 Research Prize for Young Scientists

October 31, 2016

38-year-old Alexander N. Zelikin is an associate professor at the Department of Chemistry and iNANO at Aarhus University in Denmark. He is at the forefront of the design of medical polymer materials, and his research focuses on developing technologies able to solve highly complex medical issues.

The Zelikin group, based at Aarhus University, designs hydrogel biomaterials and enzyme-prodrug therapies to perform localised synthesis of drugs using therapeutic implants. This group also develops innovative strategies to treat viral diseases, specifically using macromolecular prodrugs with a broad spectrum of antiviral activity - a pioneering strategy in the field. Zelikin has also initiated an international programme aiming to eradicate HIV from the human body using innovative prodrug design strategies.

In order to educate the next generation of medicinal chemistry and polymer researchers in Denmark, Alexander Zelikin has created some very popular courses in medicinal chemistry and drug delivery at Aarhus University. His scientific publications are frequently on the front pages of international journals, and he is often invited to give lectures at scientific conferences around the world. He has attracted significant funding from both private and public foundations, from Denmark and abroad, including the ERC Consolidator grant to carry out his pioneering research.

"Alexander N. Zelikin is a very strong scientist and a true pioneer in the research of modern drug delivery. His research helps strengthen Danish biomedical polymer research internationally. Danish polymer science has gained recognition in the international arena through his hard work.

It gives us great pleasure and pride to see that Lundbeckfonden is awarding the 2016 Research Prize for Young Scientists to one of Aarhus University's young and promising researchers," says Professor Birgit Schiøtt, who is head of the Department of Chemistry and who nominated Zelikin for the prize.

In 2001, Lundbeckfonden established a research prize for young scientists under the age of 40. The prize is awarded in acknowledgement of a particularly promising scientist who has produced outstanding research in the field of biomedical science.

Candidates are nominated for this prize by leading scientists at Danish research institutions. Lundbeckfonden's Research Committee selects the prizewinner in collaboration with external reviewers. In order to be eligible for the prize, which is a personal honorary award of DKK 300,000, the recipient must be conducting research at a Danish research institution at the time of the award.

"I am deeply honoured to receive the 2016 Research Prize for Young Scientists from Lundbeckfonden and I would like to sincerely thank my team and my collaborators, without whom my research would not be possible. I hope that this award serves as an inspiration and a motivation to all young researchers in Denmark," says Alexander N. Zelikin.
-end-


Aarhus University

Related Drug Delivery Articles:

Tiny bubbles offer sound solution for drug delivery
The blood-brain barrier protects the brain and central nervous system from harmful chemicals circulating in the blood but also prevents delivery of drugs that could help treat patients with brain cancers and diseases.
Making vessels leaky on demand could aid drug delivery
Scientists use magnets and nanoparticles to cause 'leaks' in blood vessels on demand.
Antidepressant may enhance drug delivery to the brain
New research from the National Institutes of Health found that pairing the antidepressant amitriptyline with drugs designed to treat central nervous system diseases, enhances drug delivery to the brain by inhibiting the blood-brain barrier in rats.
How molecular machines may drive the future of disease detection and drug delivery
In a study published in Nature Communications, University of Alberta researchers describe the creation of synthetic DNA motors in living cells.
Tiny magnetic implant offers new drug delivery method
University of British Columbia researchers have developed a magnetic drug implant -- the first of its kind in Canada -- that could offer an alternative for patients struggling with numerous pills or intravenous injections.
A new direction in ophthalmic development: Nanoparticle drug delivery systems
Most ophthalmic diseases are usually treated with topically administered drug formulations (e.g. eye drops).
Drug delivery modification sidesteps allergic responses
Duke has developed an altered version of the polyethylene glycol (PEG) polymer used to ferry drugs in the bloodstream that seems to evade PEG antibodies already present in humans due to its common use in consumer goods.
New capsule achieves long-term drug delivery
Researchers at MIT and Brigham and Women's Hospital have developed a drug capsule that remains in the stomach for up to two weeks after being swallowed, gradually releasing its drug payload over time.
Tiny super magnets could be the future of drug delivery
Microscopic crystals could soon be zipping drugs around your body, taking them to diseased organs.
New platform for roundworms could speed up drug delivery
Engineers at The University of Texas at Austin have developed the first large-scale in vivo drug discovery platform using C. elegans (roundworms) that could speed up scientific research and more accurately assess the effectiveness of new drugs in the treatment of neurodegenerative diseases, including Parkinson's and Huntington's disease.

Related Drug Delivery Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...